Default company panoramic image
Logo

Thar Pharmaceuticals

Thar Pharmaceuticals reinvents known, safe, on-the-market drugs by improving their clinical performance and economic benefits.

  • Stage Product In Development
  • Industry Biotechnology
  • Location Pittsburgh, PA, USA
  • Currency USD
  • Founded January 2007
  • Employees 8
  • Website tharpharma.com

Company Summary

Thar reinvents known, safe on-the-market drugs by improving their clinical performance and economic benefits. We transform intravenous drugs into oral drugs, thus eliminating the cost of IV drug administration, a $34 billion annual cost paid by health systems, patients and insurers. Our lead product is an oral form of an existing $2.1 billion IV-only bone metastasis drug that can save up to $3,900 per patient per year in IV administration costs.

Team

  • Default avatar
    Brian Moyer
    VP, Corporate Development

  • Default avatar
    Jason Bablak, JD
    VP, Regulatory Affairs

  • Default avatar
    Raymond Houck
    Chief Executive Officer

  • Default avatar
    Mazen Hanna, PhD
    Chief Scientific Officer

  • Default avatar
    Ira Kalfus, MD
    Chief Medical Officer

Advisors

  • Default avatar
    Paul DeRosa, Cohen & Grigsby
    Lawyer
    Unconfirmed
    Default avatar
    John Yanak, Grossman, Yanak & Ford
    Accountant
    Unconfirmed

Previous Investors

  • Default avatar
    Thar Technologies
    Unconfirmed
    Default avatar
    Innovation Works
    Unconfirmed
    Default avatar
    Private Individuals and family offices
    Unconfirmed